De Beers' July Price Reset Shows the Diamond Debate Has Moved Past "Either/Or"

A market signal from the rough end

The most consequential diamond headline this month did not arrive in a bridal campaign or a celebrity ring reveal. It came from the wholesale pipeline. At De Beers' July sales cycle, the miner reportedly made broad cuts to official rough-diamond prices, bringing them closer to the secondary market, while reducing its contracted "sightholders" from roughly 70 to 45–50. The scale of the cuts has not been publicly disclosed; De Beers declined to comment to the reporting cited by Engineering News. That distinction matters. The direction of travel is clear, even if an exact percentage is not.

It is a notable departure for a company long associated with protecting a price structure through tightly managed supply. The reset arrives as its parent, Anglo American, works to sell its De Beers stake, against a prolonged weak market for mined diamonds. Reuters reported on July 17 that Botswana is considering its options after Anglo selected a preferred buyer; the process remains subject to approvals and was not final at publication.

Lab-grown diamonds are not the sole cause of this moment. Softer Chinese demand, trade disruption, and supply dynamics also shape the natural market. Yet lab-grown supply has unmistakably changed the comparison consumers make, especially in bridal: a visually near-indistinguishable diamond can be offered at a much lower ticket. The Gemological Institute of America says laboratory-grown and natural diamonds have essentially the same chemical composition, crystal structure, optical and physical properties; conventional observation cannot reliably separate them. Advanced laboratory testing can.

That is the commercial fact behind the cultural argument. For customers choosing with their eyes, a larger or higher-specification lab-grown stone can make a dramatic visual proposition. For customers buying scarcity, geological origin, provenance or a particular story, the natural stone remains a different proposition even when its optical performance is comparable.

The retailer's answer: carry both, but do not treat them as identical businesses

Big retailers are already behaving as though the market has two durable lanes. Signet Jewelers, which operates Kay, Zales, Jared, Blue Nile and Diamonds Direct, reported in its fiscal 2026 annual filing that about 27% of merchandise sales were products containing lab-grown diamonds. Its brands offer both natural and lab-grown choices, and the company sources and processes both kinds of rough. That is not a niche side bet; it is an operating reality at the largest specialist retailer in the U.S.

But the same SEC filing gives the more useful lesson. Signet says increased gem-quality lab-grown supply has reduced their cost and retail price and may pressure revenue and merchandise margins, particularly for unbranded stones without special designs or cuts. In other words, a lab-grown diamond can be excellent consumer value while still being a hard product for a retailer to build stable dollar margins around. Lower prices make carat weight easier to sell; they can also make yesterday's price look awkwardly high and turn a once-luxury purchase into a more ordinary component.

That is why the best retail strategies are likely to distinguish the categories rather than pretend one will erase the other. Lab-grown fits an accessibility proposition: budget certainty, size, fashion jewelry, and the freedom to prioritize design or setting. Natural diamonds fit a differentiated luxury proposition: rarity, origin, distinctive color, antique cuts and exceptional stones. Neither lane excuses vague selling. The U.S. Federal Trade Commission says a laboratory-created diamond must be described clearly and conspicuously as laboratory-grown, laboratory-created, or with equivalent language immediately before "diamond," communicating that it is not mined. Its guidance is unusually direct because the gems can otherwise be confusingly similar, as laid out in the FTC's advertising guide.

A natural-diamond rebound—reported carefully

De Beers is making a bullish case for natural diamonds just as it adjusts its own market position, so its new research deserves both attention and a visible asterisk. On June 11, the company published a study of 18,500 U.S. women aged 18–74. It said natural diamonds were the most desired luxury-jewelry gift among respondents: 11% ranked them first, compared with 8% for synthetic lab-grown diamond jewelry. It also said point-of-sale data from 950 independent jewelers showed natural-diamond sales up 4% year over year in the fourth quarter of 2025 and 9% in the first quarter of 2026.

Those are company-reported findings, not an independent census of the whole U.S. market. They are nevertheless meaningful indicators from a major participant, and the report supplies an important counterweight to any simplistic "lab has won" headline. De Beers says synthetic lab-grown jewelry was growing in volume but represented 15% of independent jewelers' diamond-sales value in 2025, versus 85% for natural. Its full release deserves to be read alongside the company's commercial interest before drawing sweeping conclusions.

The most interesting detail is not the 85/15 split, but De Beers' observation that lab-grown sales fall off past three carats. That could signal an aesthetic ceiling—some buyers may decide very large white stones look less believable or less personal—or simply a segmentation effect. It is not proof that consumers reject large lab-grown diamonds everywhere. Still, it points toward an emerging retail truth: abundance does not eliminate taste. As a category becomes more attainable, design, individuality and social signaling matter more, not less.

What the price cut really says

De Beers' July move should not be read as an admission that natural diamonds have no future. It is better read as a forced acknowledgment that a premium must be continuously earned. Natural-diamond pricing can no longer rest comfortably on the absence of a convincing substitute; the substitute is now real diamond material, supplied at scale, with an increasingly familiar label.

Likewise, lower lab-grown prices are not evidence that those diamonds are inferior. They are evidence of a supply curve that behaves more like manufacturing than mining. The consumer benefit is substantial, but it comes with a practical buying implication: buyers should choose a lab-grown diamond for the piece they want to wear, not on an assumption that its retail price will be protected. The same caution applies, in a different way, to natural diamonds: most jewelry purchases are not liquid investments, and a natural origin alone does not guarantee resale performance.

For jewelers, the durable advantage is not choosing a camp. It is explaining the trade-off honestly, showing the design value around the stone, and matching the product to the occasion. For the industry, July's rough-price reset makes the conclusion harder to avoid: the next diamond market will be less about defending one word—"real"—and more about being precise about origin, price and promise.